Review article · 2026
Nano‐Therapeutics for In Vivo Immune Cell Engineering
Small Methods, 10(10), e01973 · Published 1 May 2026 · DOI 10.1002/smtd.202501973
In brief
“Nano‐Therapeutics for In Vivo Immune Cell Engineering” is a 2026 review article by Yuanyuan Geng and 9 co-authors, published in Small Methods. OpenAlex counts 3 citations as of 18 November 2026, which puts it in the top 4% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 3
- Most cited in
- 2026 (3)
- Field-weighted impact
- 2.06
- References
- 112
- Authors
- 10
Abstract
Immune cell engineering, exemplified by chimeric antigen receptor T (CAR-T) cell therapy, has revolutionized the treatment of various diseases, particularly cancers. While significant advancements have been made in ex vivo immune cell editing, progress in in vivo engineering has been comparatively slower despite its substantial potential advantages, such as reduced manufacturing complexity and cost. However… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Geng, Y., Wang, Z., Liu, X., Yao, H., Sun, J., Lao, Y., Lv, S., Xie, X., Tao, Y. R., & Li, M. (2026). Nano‐Therapeutics for In Vivo Immune Cell Engineering. Small Methods, 10(10), e01973. https://doi.org/10.1002/smtd.202501973
MLA 9
Geng, Yuanyuan, et al. “Nano‐Therapeutics for In Vivo Immune Cell Engineering.” Small Methods, vol. 10, no. 10, 2026, p. e01973. https://doi.org/10.1002/smtd.202501973.
Chicago
Geng, Yuanyuan, Ziqi Wang, X Liu, Haochen Yao, Jiali Sun, Yeh‐Hsing Lao, Shixian Lv, Xi Xie, Y R Tao, and Mingqiang Li. 2026. “Nano‐Therapeutics for In Vivo Immune Cell Engineering.” Small Methods 10 (10): e01973. https://doi.org/10.1002/smtd.202501973.
Harvard
Geng, Y. et al. (2026) ‘Nano‐Therapeutics for In Vivo Immune Cell Engineering’, Small Methods, 10(10), p. e01973. doi:10.1002/smtd.202501973.
IEEE
Y. Geng et al., “Nano‐Therapeutics for In Vivo Immune Cell Engineering,” Small Methods, vol. 10, no. 10, p. e01973, 2026, doi: 10.1002/smtd.202501973.
BibTeX
@article{geng2026nano,
title = {{Nano‐Therapeutics for In Vivo Immune Cell Engineering}},
author = {Geng, Yuanyuan and Wang, Ziqi and Liu, X and Yao, Haochen and Sun, Jiali and Lao, Yeh‐Hsing and Lv, Shixian and Xie, Xi and Tao, Y R and Li, Mingqiang},
journal = {Small Methods},
year = {2026},
volume = {10},
number = {10},
pages = {e01973},
doi = {10.1002/smtd.202501973},
url = {https://doi.org/10.1002/smtd.202501973}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- nanotherapeutics
- chimeric antigen receptor T cells
- CAR T-cell therapy
- genome editing
- targeting specificity
- long-term safety
- clinical translation barriers
- cancer immunotherapy
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Geng, Y., Wang, Z., Liu, X., Yao, H., Sun, J., Lao, Y., Lv, S., Xie, X., Tao, Y. R., & Li, M. (2026). Nano‐Therapeutics for In Vivo Immune Cell Engineering. Small Methods, 10(10), e01973. https://doi.org/10.1002/smtd.202501973
How many times has this paper been cited?
3 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Yuanyuan Geng, Ziqi Wang, X Liu, Haochen Yao, Jiali Sun, Yeh‐Hsing Lao, Shixian Lv, Xi Xie, Y R Tao, Mingqiang Li.
What is the DOI of this paper?
10.1002/smtd.202501973, permanently at https://doi.org/10.1002/smtd.202501973. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.